- Filed
- Jun 12, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Jun 10, 2026 | 8.7M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 8.48M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 8.55M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 5.19M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 5.16M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $79.27K |
| Capex | Q2 2026 · Mar 31, 2025 | $27.59K |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$4.44M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $151.91K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $2.8M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $6.57M |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2026 | $5.08M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $6.4M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $7.07M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $1.13M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $2.94M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $822.01K |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $1.69M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $2.3M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $2.49M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $3.71M |
| Current Assets restated | Q2 2026 · Mar 31, 2026 | $7.11M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $10.23M |
| Total Assets restated | Q2 2026 · Mar 31, 2026 | $7.57M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $10.79M |
| Eps Diluted restated | Q2 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2026 | −$0.47 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$0.44 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic restated | Q2 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic restated | Q2 2026 · Mar 31, 2026 | −$0.45 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$0.44 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $1.92M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $3.8M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $1.94M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $3.98M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $1.47M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $2.86M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $1.51M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $2.68M |
| Net Income restated | Q2 2026 · Mar 31, 2026 | −$2.38M |
| Net Income restated | Q2 2026 · Mar 31, 2026 | −$3.82M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$1.44M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$2.27M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$485.29K |
| Net Income | Q2 2026 · Dec 31, 2024 | $1.79M |
| Operating Income restated | Q2 2026 · Mar 31, 2026 | −$2.4M |
| Operating Income restated | Q2 2026 · Mar 31, 2026 | −$4.1M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$2.68M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$968.81K |
| Gross Profit restated | Q2 2026 · Mar 31, 2026 | $990.26K |
| Gross Profit restated | Q2 2026 · Mar 31, 2026 | $2.56M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $771.06K |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $2.7M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2026 | $871.79K |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2026 | $2.2M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $615.49K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $1.96M |
| Revenue restated | Q2 2026 · Mar 31, 2026 | $1.86M |
| Revenue restated | Q2 2026 · Mar 31, 2026 | $4.75M |
| Revenue | Q2 2026 · Mar 31, 2025 | $1.39M |
| Revenue | Q2 2026 · Mar 31, 2025 | $4.66M |